1-3 of 3
Brian A Costello
Close
Sort by
Journal Articles

Copanlisib in Combination with Nivolumab in Subjects with Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Primary Mediastinal Large B-Cell Lymphoma: A Phase II Study

N. Nora Bennani, Pamela Atherton, Kimberly O Steinert, Lisa M. Rimsza, Aung M. Tun, Marc S. Hoffmann, Mayur S. Narkhede, Rakhee Vaidya, Rabih Said, Geoffrey I Shapiro, Brian A Costello, Stephen M Ansell, Grzegorz S. Nowakowski
Journal: Blood
Blood (2023) 142 (Supplement 1): 4475.
https://doi.org/10.1182/blood-2023-190540
Published: 2023
Journal Articles

A Multicenter Phase I Dose-Escalation Trial of a Novel Glutaminase Inhibitor Telaglenastat in Combination with Carfilzomib and Dexamethasone in Relapsed and Refractory Multiple Myeloma

Wilson I. Gonsalves, Natalia Neparidze, Jacob B. Allred, Shaji K Kumar, Joel M. Reid, Geoffrey Shapiro, Brian A. Costello, Richard Piekarz, Rachid C. Baz, Srinivas Devarakonda
Journal: Blood
Blood (2022) 140 (Supplement 1): 7315–7316.
https://doi.org/10.1182/blood-2022-164966
Published: 2022
Journal Articles

Single-agent ibrutinib in relapsed or refractory follicular lymphoma: a phase 2 consortium trial

Clinical Trials & Observations
Nancy L. Bartlett, Brian A. Costello, Betsy R. LaPlant, Stephen M. Ansell, John G. Kuruvilla, Craig B. Reeder, Lim S. Thye, Daniel M. Anderson, Kilannin Krysiak, Cody Ramirez, Jing Qi, Barry A. Siegel, Malachi Griffith, Obi L. Griffith, Felicia Gomez, Todd A. Fehniger
Journal: Blood
Blood (2018) 131 (2): 182–190.
https://doi.org/10.1182/blood-2017-09-804641
Published: 2018
Includes: Supplemental data